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Abstract: Nowadays, obesity is one of the great nutritional problems facing public health. The
prevalence of this pathology has increased in a worrying way over recent years, currently reaching
epidemic proportions. In this context, nutritional supplements are presented as a therapeutic
alternative to which more and more people are turning to. Nutritional supplements to lose weight
based on the Garcinia plant, specifically on Garcinia cambogia, are commonly used. The active principle
of this plant to which these properties have been attributed, is hydroxycitric acid (HCA). The aim of
the present review is to gather reported data concerning the effectiveness of nutritional supplements
based on Garcinia extracts on weight loss and their possible negative effects. Contradictory results
have been observed regarding the effectiveness of the supplements. While statistically significant
weight loss was observed in some studies, no changes were found in others. Regarding safety,
although Garcinia supplements have been revealed as safe in the vast majority of the studies carried
out in animal models and humans, some cases of hepatotoxicity, serotonin toxicity and mania
have been reported. In conclusion, the results suggest that Garcinia-based supplements could be
effective in short-term weight loss, although the data are not conclusive. In addition, the safety of the
complement should be further studied.
Keywords: Garcinia cambogia; nutritional supplements; weight loss; hepatotoxicity; serotonin toxicity
1. Introduction
Obesity is one of the most common nutritional problems worldwide, currently reach-
ing epidemic proportions. This pathology was previously considered typical in developed
countries, but nowadays it also shows a high prevalence in underdeveloped countries.
According to figures from the World Health Organization (WHO), in 2019 more than
1.9 billion adults aged≥18 years were overweight, and of them more than 650 million were
obese [1]. Since 1975 the worldwide prevalence of obesity has tripled, thus leading to a
major public health problem. Obesity is associated with a large number of comorbidities,
such as type 2 diabetes mellitus, hypertension, dyslipidemia, non-alcoholic fatty liver
disease and cardiovascular diseases, among others. Furthermore, according to the WHO,
people with obesity have a 50 to 150% increased risk of death from any cause compared to
individuals with normal weight [2].
Hypocaloric diets and physical activity based treatments for overweight and obesity
represent the first line of therapy. Due to the difficulty in achieving and maintaining an
adequate adherence to this treatment, many people often turn to nutritional supplements
that promise to help them lose weight in the short run or at least, to maintain it. For many
people it is an easy solution, which enables them not to modify their lifestyle too much. In
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many instances, the motivation for the use of these supplements is due to aesthetic reasons,
since the beauty standards that mark our society today encompass being slim.
These supplements work through five basic mechanisms, these being stimulation
of thermogenesis, reduction in lipogenesis, increase in lipolysis, suppression of appetite,
and decrease in lipid absorption. Among these nutritional supplements we find those
based on plant extracts, which have been used for many centuries in the Eastern world.
Nowadays, their use has become more and more prevalent throughout the world. Among
them, Garcinia cambogia is one of the most promoted as a potential anti-obesity agent and
has received a lot of attention in the media [3].
Although the current consumption of herbs and dietary supplements is unknown,
in a study carried out in six European countries, it was estimated that 18.8% of the 2358
consumers selected for the study consumed one or more dietary supplements, not taking
into account herbal products. The percentages of plant food supplement consumers were
9.6% in Finland, 16.9% in Germany, 22.7% in Italy, 17.9% in Romania, 18.0% in Spain and
19.1% in the United Kingdom [4].
The aim of this review is to gather the reported information concerning both the
effectiveness and the side-effects of nutritional supplements based on Garcinia cambogia to
promote weight loss. In addition, the efficacy of other Garcinia species is also presented.
For this purpose, a selective literature search in PubMed and Cochrane databases was
performed. To search for the effects on body weight loss, the terms Garcinia, HCA, weight
loss, fat mass and obesity were introduced, adding “and”, “or”, “not” to improve the
classification. In addition, the filters “clinical trial” and “meta-analysis” were used. To
search for toxic effects, the terms Garcinia, HCA and toxic effects were used. In the
Cochrane Library database we sought the term “Garcinia” in the title or the abstract in
meta-analyses and clinical trials. The search was extended to a total of 25 years (Figure 1).
Figure 1. Flow chart showing the process for the inclusions of articles.
2. Active Principle and Mechanisms of Action
The genus Garcinia, native to Asia and Africa, belongs to the Clusiaceae family and
includes more than 300 species, such as Garcinia cambogia (Figure 2), Garcinia mangostana and
Garcinia atroviridis [5]. Potential therapeutic effects, such as anti-obesity, anti-ulcerogenic,
antioxidant, anti-diabetes, anti-fungal, anti-inflammatory and anti-neoplasic [6], have
been attributed to this genus. This has led to multiple investigations by pharmaceutical
companies [5]. Some of the bioactive compounds isolated from Garcinia are garcinol,
isogarcin, (−)-hydroxycitric acid (HCA), mangostin, and xanthoquimol [6]. It should be
noted that out of the species mentioned above, Garcina cambogia is the most used as a
nutritional supplement for weight loss or maintenance. The anti-obesity properties have
been attributed to HCA, which is present in the rind or epicarp of the fruit and represents
20–30% of the dry weight [7]. Many food supplements containing HCA are currently
marketed for weight reduction.
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Figure 2. Tree, branch, and fruit of Garcinia cambogia.
The effects of HCA are associated with a reduction in food intake via serotonin level
regulation and metabolic modifications, such as an increase in fat oxidation, a decrease in
de novo lipogenesis and the stimulation of hepatic glycogenesis, thus promoting energy
expenditure. HCA is a competitive inhibitor of adenosine triphosphate (ATP)-citrate lyase,
an enzyme that catalyzes the extramitochondrial breakdown of citrate into oxalacetate and
acetyl-CoA, thus limiting the availability of acetyl-CoA, a compound that plays a key role
in the synthesis of fatty acids in diets rich in carbohydrates (Figure 3).
Figure 3. Mechanisms of action of hydroxycitric acid (HCA). CPT: Carnitine palmitoyltransferase.
3. Effectiveness of Garcinia to Lose and Maintain Body Weight
In in vitro studies, HCA has been shown to inhibit fatty acid synthesis [8]. Specifically,
in isolated hepatocytes, HCA inhibits the synthesis of fatty acids from glucose, but not
from acetate. Therefore, HCA is an inhibitor of lipogenesis only if cytoplasmic acetyl-CoA
is produced by ATP-citrate lyase. Nevertheless, fatty acid synthesis is able to continue as
long as acetate, another acetyl-CoA precursor, is available. As the synthesis of acetyl-CoA
is reduced, that of malonyl-CoA is reduced too, thus decreasing the negative feedback of
carnitine acyltransferase. This produces an increase in lipid transport in the mitochondria
and inefficient oxidation, that promotes the formation of ketone bodies. These molecules
can pass into the bloodstream and reach the brain, where they constitute an energy reserve
in the event of fasting [8].
In preclinical studies using animal models, chronic oral administration of HCA to rats
significantly reduces food intake in the first hour after administration, together with body
weight and concentrations of cholesterol, triglycerides and fatty acids. When evaluating
the acute and chronic effects of HCA on energy metabolism in mice, it was observed that
Nutrients 2021, 13, 450 4 of 19
oral administration of 10 mg increased serum concentration of free fatty acids and glycogen
concentration in skeletal muscle [9].
Leonhardt et al. (2002) studied the long-term effect of HCA in male Sprague–Dawley
rats after a notable body weight loss in two different experiments. Each experiment had 23
or 24 rats, respectively [10]. The rats were fed a 1% fat diet or a 12% fat diet, depending on
the experiment. Both diets were supplemented with 3% HCA. HCA produced a long-term
reduction in body weight recovery in both groups (in both rats fed 1% fat or 12% fat diets).
However, only HCA produced a long-term suppressive effect in the case of the group of
rats fed the 12% fat diet. No effect on plasma β-hydroxybutyrate levels was observed, so
the hypothesis that increased fatty acid oxidation in the liver is involved in suppressing
food intake by HCA was not supported by these results [11]. In another study, young lean
and obese female Zucker rats were fed a diet (70% glucose, 1% corn oil) supplemented
with HCA (52.6 mmol/kg diet) for 39 days. Amongst the lean rats, HCA decreased food
intake, body weight, the percent of body fat, and fat cell size. Amongst the obese rats, food
intake and body weight were lowered, but body fat percentage remained unchanged [10].
In other studies, instead of isolated HCA, extracts of Garcinia were used for sup-
plementation. Saito et al. (2005) studied the ability of a Garcinia cambogia extract, con-
taining HCA, to suppress the accumulation of body fat in growing male obese Zucker
rats (6 weeks) [12]. They were given diets containing different amounts of the extract,
which provided 10, 51, 102 or 154 mmol of HCA/kg of diet, respectively, for 92–93 days.
Rats fed the highest amount of extract, and therefore receiving the highest dose of HCA
(154 mmol HCA/kg diet), significantly decreased epididymal fat accumulation, compared
to the other groups.
Table 1 presents a summary of the results obtained in 20 reported intervention studies
in humans [13–32]. In 12 studies, statistically significant reductions in body weight were
observed [14,15,18–22,26–28,30,31]. Conversely, the supplementation turned out to be
ineffective in the remaining studies [13,16,17,23–25,29,32]. In the studies where significant
weight loss was observed, the average value was between 2 and 6 kg in 2–4 months, with
the exception of one where a loss of 14 kg was induced in 6 months [31]. Interestingly, in
11 studies [19–21,23,24,26,27,29–32], significant reductions in other parameters, such as
waist and hip circumference, triglycerides, cholesterol and glucose were also observed
regardless of body weight loss. It was specified in the vast majority of the studies that the
supplement should be consumed approximately half an hour before meals. Splitting the
doses of HCA has also been shown to be more effective than utilizing the same amount
given as a single dose.
Table 1. Characteristics and results of published intervention studies in humans.
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Of note, important differences in the experimental design can be observed among
the reported studies. The number of participants ranged from 11 to 214. The fact that
the majority of the studies had a small sample size limits the reliability of the results.
In addition, in some cases there is a lack of proportion between men and women. The
inclusion of both genders is important in order to determine whether there is sexual
dimorphism in the effectiveness of the nutritional supplement. Conversely, in all the
selected studies, the participants were overweight or obese (based on body mass index)
and the duration of treatments ranged from 2 to 4 months in the majority studies, with the
exception of two longer ones, in which the duration was 6 or 6.5 months.
The variability is also observed in the type of supplement administered. Upon that,
Garcinia cambogia/HCA was used in 15 studies, Garcinia mangostana in four studies and
Garcinia artroviridis in one study. Lastly, in some cases HCA or Garcinia appeared to be
combined with other ingredients, such as glucomannan (fiber), Sphaeranthus indicus or
Coffea arabica. Consequently, it is not possible to determine whether the effect produced
was due to the HCA content, to other ingredients, or to a combination of the effects of
the different ingredients. The dose administered is another differential aspect among
the studies. Last of all, the presentation of the supplement is different (pills, capsules or
sachets). It is indicated in all cases that the supplement should be consumed before the
meal (approximately half an hour before).
Differences in other aspects of the experimental design, such as diet and physical
activity can also be found. In some studies, the participants were instructed to continue with
their usual diet and physical activity, while in others they were given specific instructions.
Lastly, in others they were prescribed a hypocaloric diet along with specific practice of
regular physical activity.
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Some of these differential aspects could explain the lack of effect observed in sev-
eral studies, for instance, the lowest sample size in the studies reported by Kovacs et al.
(2001) [16], Kovacs et al. (2001) [17] and Watanabe et al. (2018) [32] In the study reported
by Heymsfield et al. (1998) [13], Garcinia cambogia was not effective since the diet was low
in energy and high in fiber. The amount of fiber could have inhibited the gastrointestinal
absorption of HCA (active compound in Garcinia cambogia) and the low energy supplied
(approximately 1200 Kcal) could have affected the usefulness of HCA. In addition, the dose
of HCA was lower than that used in other studies. Another parameter that could have
an influence was the excess of calcium used to stabilize HCA, that could have reduced
the solubility of this bioactive compound, and therefore its bioavailability [8]. In a similar
way, the lack of effect in the studies carried out by Roongpisuthipong et al. (2007) [21] and
Vasques et al. (2014) [29] could be related to the low amount of energy provided by the
diet (1000 Kcal/d and 1500 Kcal/d, respectively). In the study conducted by Vasques et al.
(2008) [23], the only apparent potential reason could be that neither dieting, nor practicing
physical activity were recommended. In contrast, in all the studies in which positive results
were obtained, a healthy lifestyle was either prescribed or recommended. Last of all, in the
studies conducted by Kim et al. (2011) [24] and Hayamizu et al. (2003) [18], in an Asian
population, it is believed that the fact that the fruit of the Garcinia is of common use as part
of the traditional diet, could have led to a reduced susceptibility to its effects.
Onakpoya et al. (2011) published a systematic review and meta-analysis of random-
ized clinical trials devoted to evaluating the effectiveness of Garcinia extracts as weight
reduction agents [33]. The authors concluded that these extracts generated short-term
weight loss. However, the scale of this effect was small, since it was not statistically sig-
nificant when only rigorous randomized clinical trials were considered. Therefore, the
clinical relevance of these products appears to be questionable and they do not represent
an altogether effective measure of the treatment of overweight and obesity.
4. Negative Effects on Health
4.1. Animal Toxicity Studies
Studies of acute, short-term, sub-chronic, and chronic toxicity, as well as studies
of genotoxicity, cytotoxicity and toxicity in reproduction, have been conducted in dif-
ferent animal species, although mainly in rats and rabbits. These studies have shown
that Garcinia/HCA have good safety profiles, so that they may be used as nutritional
supplements for the treatment of obesity [34–36].
Ohia et al. (2002) evaluated the effects of Super Citri-Max™, a novel calcium/potassium-
HCA extract (HCA-SX), containing 60% HCA, administered for 14 days. This extract is
considerably more soluble and bioavailable than calcium-based HCA ingredients [37]. The
study was conducted in Albino rats (males and females) fed ad libitum, treated with a
dose of 5000 mg/kg (through a gastric probe), which is equivalent to 350 g or 233 times
the maximum dose of 1.5 g/day of HCA in humans. The authors did not report any
death or significant clinical changes. Furthermore, no significant tissue injuries were ob-
served during the necropsy, which led them to suggest that the LD50 oral administration
of HCA-SX in rats was over 5000 mg/kg. Similarly, in another study carried out by the
Wil Research Laboratories, it was shown that 5000 mg HCA/kg of body weight did not
produce visible symptoms of toxicity or death in animal models. In line with these studies,
Clouatre et al. (2013) defended that HCA was extremely safe and this was corroborated by
various reviews where it was claimed that HCA from Garcinia cambogia had a protective
effect on the liver [38].
Shara et al. (2003) analyzed the effects of HCA intake on weight, testicular and
liver lipid peroxidation, and DNA fragmentation, in addition to possible histopatholog-
ical changes in Sprague–Dawley rats [39]. The animals received 0.2, 2.0, or 5.0% HCA
(100–2500 mg/kg) in their diet, equivalent to approximately 100, 1000, and 2500 mg/kg/day,
respectively, in humans. The lowest dose was equivalent to the daily recommended dosage
in humans, but the doses of 2.0 and 5.0% are 10 to 25 times higher doses. The rats were
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euthanized at 30, 60, and 90 days of treatment. After 90 days of HCA administration, rats
showed decreased body weight, without changes in liver or testicular lipid peroxidation or
in DNA fragmentation In a follow-up study, the same authors did not find differences in
the weight of various organs. Moreover, no haematological or biochemical disorders or
significant histopathological changes or mortality differences were found [40].
As an exception, Kim et al. (2013) in a study addressed in rats fed a high-fat diet (45%
of total energy), it was shown that after 16 weeks of treatment with Garcinia cambogia (1%,
w/w, 60% HCA) oxidative stress, inflammation and liver fibrosis were triggered [41]. Con-
sequently, it appears that the form of HCA regarding its extraction process and the residual
compounds, among other factors, may spur differences between study outcomes [42].
Toxicological studies have been also addressed with other Garcinia species. Farombi et al.
(2013) carried out a study in adult male Wistar rats randomly assigned to four groups of
10 rats each group given Garcinia kola orally at different doses (0, 250, 500 and 1000 mg/kg)
for 6 weeks [43]. After conducting the study, it was concluded that the administration of
Garcinia kola increased the antioxidant status and did not produce adverse effects on the
liver, testicles and sperm. Saiyed et al. (2015) performed various toxicological studies both
in vitro and in animals to evaluate the safety of Meratrim™, a supplement that contains
Garcinia mangostana [44]. Meratrim™ was determined to be non-irritating to the skin, mildly
irritating to the eyes, not mutagenic, and the no-observed-adverse-effect level (NOAEL) for
this supplement was 1000 mg/kg body weight/day (in Sprague–Dawley rats). The authors
concluded that the safety of Meratrim was demonstrated given the results observed in this
study, added to the clinical trials of tolerability already carried out.
4.2. Clinical Toxicity
Based on toxicological studies, Soni et al. (2004) noted that there was sufficient
quantitative and qualitative scientific evidence, from both animal and human data, to
suggest that HCA intake up to 2800 mg/day is safe for human consumption [35]. As a
result, a NOAEL of 2800 mg/d was established [34,35].
Accordingly, none of the studies included in Table 1, devoted to analyzing the effects of
Garcinia on body weight reductions at doses below this value have found serious adverse
effects. Some of the minor side effects observed were leg cramps, heartburn, diarrhoea,
increased gas, higher appetite, headaches, heartburn, rash, menstrual bleeding, and general
weakness. In spite of this, other authors have reported toxic manifestations, including
hepatotoxicity, acute pancreatitis, serotonin toxicity and psychosis after the consumption of
Garcinia-containing products (either as an extract containing other components or pure). In
16 of the 21 cases described in Table 2 [45–60], these adverse effects have occurred after the
intake of formulations which contained other ingredients besides Garcinia. One of these
formulations is Hydroxycut™. Fourteen different products are marketed under this name,
but only eight of them contain Garcinia cambogia. In addition, all of them are polyherbal
products that can contain up to 20 different substances [34]. When toxic effects are induced
by supplements that, in addition to Garcinia, contain other components, it has not been
possible to confirm that Garcinia is the agent responsible for the side-effects. In spite of this,
the FDA (US Food and Drug Administration) issued a warning in 2009 on Hydroxycut™
products related to hepatotoxicity, which led to the recall of these products.
Table 2. Cases of liver damage associated with the consumption of Garcinia cambogia supplements in humans.
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M: men; W: women; ALT: alanine aminotransferase; AST: aspartate aminotransferase; AF: alkaline phosphatase; GGT: gamma-glutamyl
transferase; TB: total bilirrubin; DB: direct bilirrubin; INR: international normalized ratio; PT: prothrombin time; CRP: C-reactive protein;
CT: computed tomography; MRCP: magnetic resonance cholangiopancreatography; MR: magnetic resonance; CIOMS/RUCAM: scale for
diagnosing drug-induced liver damage; MELD: scale to measure the severity of chronic liver disease. In cases where information about
dose is not provided, it is because it was not indicated in the article.
The FDA warned consumers about the serious adverse effects associated with the
consumption of Hydroxycut™. This recommendation was based on 23 cases of liver
damage, including one death and a liver transplant. All this led to the withdrawal of the
supplement from the market. Later on, García-Cortés et al. (2016) reported 29 cases of liver
damage induced by this supplement [61].
Taking this into account, as it can observed in Table 2, hepatotoxic effects have also
been reported when using pure Garcinia cambogia extracts [49,50,54] or supplements that
only contained Garcinia cambogia with minerals or vitamins [53,55,56]. The reason that
justifies the occurrence of hepatotoxic effects in these cases, but not in all the studies
gathered in Table 1, is not clear. Genetic interindividual variability leading to different
susceptibility to the action of Garcinia cannot be ruled out. Nevertheless, it is important
to emphasize that counting all the subjects that participated in the studies described in
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Table 1, the lack of toxic effects refers to a quite big sample, whereas toxic effects have only
been described in a reduced number of subjects.
The common pattern of symptoms, observed in all these cases, consisted of abdom-
inal pain (predominantly in the right upper quadrant), vomiting, nausea, fatigue and
alterations in liver parameters such as transaminases, alkaline phosphatase and bilirubin.
Serological tests were performed to rule out other possible causes of liver damage and/or
infection, such as hepatitis, Epstein–Barr virus, cytomegalovirus, etc. In eight cases the
CIOMS/RUCAM scale was used. This scale is a scoring system used to establish the etiol-
ogy of drug-induced liver damage, and depending on the score obtained, the substance is
classified as a highly probable cause (≥9), probable cause (6–8), possible cause (3–5), unlike
cause (1–2) or excluded cause (0) of liver injury. The scores obtained for the supplements
in these studies ranged from 6 to 11 points; in other words, probable to highly probable
cause. Importantly, after Garcinia supplement withdrawal, the symptoms subsided and all
the altered parameters returned to normal levels, although in four cases the patient finally
required liver transplantation.
Regarding acute pancreatitis, one case has been reported in an 82-year-old man with
past medical history of obesity and two previous episodes of acute pancreatitis in the past.
He denied any alcohol use and reported no recent changes in his medications, as well as
the intake of Garcinia cambogia recently as an appetite suppressant. He was treated with
bowel rest and intravenous fluid hydration, providing a significant improvement in his
symptoms [62].
Other adverse effects associated with Garcinia cambogia ingestion are mania and psy-
chosis, as shown in Table 3 [63–66]. Nevertheless, currently the existing scientific evidence
is limited and a causal association has not yet been established with certainty. In some
cases, the participants had a previous psychiatric history and/or were treated with se-
lective serotonin reuptake inhibitors (SSRI). HCA acts as a selective serotonin reuptake
inhibitor, thus increasing serotonin levels and increasing the risk of toxicity due to this
neurotransmitter [63,66]. The most relevant symptoms were irritability and agitation. After
the withdrawal of the supplement, the symptoms remitted, and all the altered parameters
returned to normal levels.
To conclude, another type of toxicity associated with the consumption of Garcinia
cambogia can be observed in patients with pre-existing metabolic disorders. In this line,
Bystrak et al. (2017) described the case of a 56-year-old insulin-dependent, hypertensive
woman with chronic hepatitis C, who developed diabetic ketoacidosis, pancreatitis, and car-
diomyopathic stress after consuming a Garcinia cambogia supplement (1400 mg HCA/day)
to lose weight [67]. Applying the algorithm described by Naranjo et al. (1981) [68] to
estimate the causality of an adverse drug reaction, a value of five was obtained, meaning a
probable adverse reaction to the use of Garcinia cambogia [67].
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5. Concluding Remarks
The reported scientific literature shows that nutritional supplements based on Garcinia
extracts are effective in just over half of the reported studies. In these cases, the supplements
should not constitute a treatment per se but, they should represent complementary tools to
the conventional treatment of excess body fat. Moreover, due to their positive effects on
lipid and glycemic profile, these supplements could be useful for the management of the
co-morbidities associated with obesity.
Garcinia-based supplements have been shown to be safe in numerous human exper-
iments, but the growing number of cases that report significant adverse effects, mainly
associated with liver damage, and to a lesser extent with serotonin toxicity and mania,
may lead to reconsideration of the safety of them. Although very often HCA has been
signaled as the main element responsible for the toxic effects of Garcinia supplements,
it should be noted that the fruit of Garcinia cambogia, an important source of HCA, has
been consumed for centuries in Southeast Asia and has been generally recognized as safe
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(GRAS) [69]. On the other hand, as explained before in this review, in many cases Garcinia
supplements contain a great number of components. Consequently, the toxicity cannot be
reliably attributable to Garcinia, and it is difficult to make conclusions without giving rise
to doubts or objections. Furthermore, potential negative effects due to the combination of
the Garcinia supplement with other dietary supplements included in the consumer diet, or
even with several drugs, cannot be discarded.
Importantly, adverse effect case reports usually reflect the associations between the
observed toxicity and the intake of the dietary supplement, rather than causality. These
associations need to be rigorously examined and, if finally, the supplements are found
to be the causative factors for the alterations observed, the true agents need to be firmly
identified, along with the dose at which the negative effects are induced [69]. In this regard,
an important problem in diagnosing the cause that produces the adverse effects, is that
many people perceive these type of products as not harmful or as “natural” products, thus,
they tend to forget to mention them when they are asked about the foods, beverages and
medications that they have consumed. It is therefore likely, that there are more cases than
those diagnosed, and consequently, the magnitude of the problem may be underestimated.
When the dose administered or the exact content of HCA are not specified, it is not possible
to identify whether the dose exceeds the value established as NOAEL. Another important
aspect, is that the issue of obesity-related liver co-morbidities as a cause of liver alterations,
has been poorly handled in toxic effect reports. Much more attention should be paid to
obesity-associated liver diseases in the causality assessment of dietary supplements used
for weight reduction [70].
In this scenario, more studies are needed to evaluate the efficacy and safety of these
products, using larger sample sizes and longer follow-up periods. Finally, it should be
pointed out that there are certain population groups in which the use of these supplements
should be discouraged. This is the case for pregnant and lactating women. HCA can affect
the production of fatty acids and cholesterol, and can directly influence the production
of sterols and steroid hormones. Pregnancy is a time of extreme sensitivity to steroid
hormones, therefore, these products are not recommended. In the case of children—
although it has not been possible to prove that they are dangerous—the advice is not to
consume them in large doses and for long periods of time. On the other hand, the evolution
of patients with mild depression or with occasional episodes of hypomania who consume
Garcinia should be monitored, since their situation may worsen.
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